aTyr Pharma Announces Second Quarter 2026 Results, Program Prioritization and Corporate Restructuring to Support Efzofitimod Program in ILD
Globe Newswire•07/08/2026•16:01 ET
0
Whiz Insights
Get started
Create a free account to read the full story.
Create a free account to read the full story.